Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment

Clinical trial NCT02695121 · COMPLETED

Trial details

NCT number: NCT02695121
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Cancer Bladder Cancer

Start date: 2017-01-01
Primary completion: 2025-01-30
Enrollment: 2133575

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.